e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Environmental exposure and other risk factors for airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bone mineral density is associated with the risk of non-small cell lung cancer, the HUNT study
P. Hatlen, A. Langhammer, B.H. Grønberg, S.M. Carlsen, S. Forsmo, T. Amundsen (Trondheim, Levanger, Norway)
Source:
Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Session:
Environmental exposure and other risk factors for airway diseases
Session type:
Poster Discussion
Number:
3396
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Hatlen, A. Langhammer, B.H. Grønberg, S.M. Carlsen, S. Forsmo, T. Amundsen (Trondheim, Levanger, Norway). Bone mineral density is associated with the risk of non-small cell lung cancer, the HUNT study. Eur Respir J 2012; 40: Suppl. 56, 3396
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Bone metabolic markers in detecting bone metastasis of lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Serum hepcidin and iron are associated with non-small cell lung cancer stage
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Lung cancer
Source: Respipedia Article
Year: 2018
Determinants of the performance status in stage IV nonsmall cell lung cancer - results of a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001
Breast metastasis in association with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005
The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Chemotherapy improves low performance status lung cancer patients
Source: Eur Respir J 2007; 30: 1186-1192
Year: 2007
Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006
SNP Rs11614913 in miR-196a is a risk factor for non-small cell lung cancer in Iranians
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Advanced non-small cell lung cancer in elderly patients
Source: Breathe 2012; 9: 26-34
Year: 2012
Changes in body compositon in men and women with advanced non-small cell lung cancer (NSCLC) undergoing chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 752s
Year: 2006
Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009
Usefulness of bone metabolic markers in the bone metastasis from lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002
Risk factor for survival in never-smokers non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
Association of Pre-miR-rs2910164 polymorphism with non-small cell lung cancer in an Iranian population
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
A non-small cell lung cancer modelling by endogenous κ-ras manipulation
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
Small cell lung cancer in patients with elderly
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept